Myracle Therapeutics Inc

Biotechnology company · East Hanover, New Jersey, United States

Myracle Therapeutics Inc is a biotechnology company headquartered in East Hanover, New Jersey, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $324,466 in total, most recently in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Myracle Therapeutics at a glance

Typebiotechnology company

HeadquartersEast Hanover, New Jersey, United States

Employees (self-reported, 2024)2

What does Myracle Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $324,466 in total (2024). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.

Frequently asked questions about Myracle Therapeutics

Where is Myracle Therapeutics headquartered?

Myracle Therapeutics Inc is headquartered in East Hanover, New Jersey, United States.

What does Myracle Therapeutics do?

Myracle Therapeutics Inc is a biotechnology company.

Similar companies

Bioinvenu CorporationEast Hanover, New Jersey, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Cognition Therapeutics IncPurchase, New York, United States
Agenus IncLexington, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences